Stock comparison
Medline Inc. is 1.6x more valuable than RESMED INC by market capitalization ($49.12 B vs $30.24 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 1.6x more valuable than RESMED INC by market capitalization ($49.12 B vs $30.24 B).
Market value leader
MDLN
Medline Inc. is 1.6x more valuable than RESMED INC by market capitalization ($49.12 B vs $30.24 B).
Revenue leader
MDLN
MDLN: $28.43B vs RMD: $5.15B.
Profit leader
MDLN
MDLN: $1.16T vs RMD: $1.40B.
Margin leader
MDLN
MDLN: 4069.4% vs RMD: 27.2% net margin.
| Metric | MDLN | RMD |
|---|---|---|
| Market cap | $49.12 B | $30.24 B |
| US-listed rank | #328 | #464 |
| Revenue (latest FY) | $28.43B | $5.15B |
| Net income (latest FY) | $1.16T | $1.40B |
| Net margin | 4069.4% | 27.2% |
| P/E (trailing FY) | 0.0x | 21.6x |
| SEC filings | 103 | 2,518 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 1.6x more valuable than RESMED INC by market capitalization ($49.12 B vs $30.24 B).
In their latest fiscal years, Medline Inc. reported $28.43B in revenue while RESMED INC reported $5.15B.
Full pages: Medline Inc. and RESMED INC, or browse the full rankings.